Certificate record
PT-141, lot 28-01260229
MZ Biolabs assayed lot 28-01260229 of PT-141 from Ascension Peptides at 99.47% purity on 10 Feb 2026, reporting 8.15 mg against a 10 mg label, 18.5% below the labelled mass.
Assayed 10 Feb 2026 · MZ Biolabs · Ascension Peptides · record id coa-ascensionpeptides-28-01260229
What the certificate reports
| Compound | PT-141 |
|---|---|
| Lot identifier | 28-01260229 |
| Purity | 99.47% |
| Labelled mass | 10 mg |
| Assayed mass | 8.15 mg |
| Difference | 18.5% below the label |
| Assay date | 10 Feb 2026 |
| Testing laboratory | MZ Biolabs |
| Who commissioned it | Published by the vendor. Scored as a claim, not as corroboration — only an independently commissioned assay counts as verified. |
| Source document | https://ascensionpeptides.com/wp-content/uploads/2026/02/COA_PT-141_quant_28-01260229_20260214.pdf |
Check it yourself
MZ Biolabs does not publish a public lookup we have been able to find, so this certificate can be read but not independently re-pulled from the laboratory. The document above is the copy the vendor published. Where a laboratory does offer a lookup, we say so and link it.
A certificate describes the sample it names and nothing else. It is not a statement about any other lot, and it is not an endorsement of the vendor or of any use of the material.
Other lots from Ascension Peptides
- VIP, lot 52-05260628 99.826% · 9 May 2026
- AOD-9604, lot 09-01260229 99.45% · 10 Apr 2026
- CJC-1295, lot 13-01260229 99.27% · 10 Apr 2026
- Ipamorelin, lot 59-03260429 99.61% · 20 Mar 2026
- MOTS-c, lot 24-01260229 99.71% · 24 Feb 2026
- ARA-290, lot 53-12250129 99.93% · 24 Feb 2026
PT-141 from other vendors
- Bench Grade Peptides, lot 00011/0011 99.76% · AV Analytics
- Vertex Labs, lot 2608190845 99.97% · Freedom Diagnostics Testing
- PeptidePlugs, lot 135-03-ZB 99.86% · Freedom Diagnostics Testing
- Origin Labs, lot Orig2607270914 99.96% · Freedom Diagnostics Testing
- PeptidePlugs, lot 115-01-RB 99.24% · Freedom Diagnostics Testing
- Next Gen Peptides, lot pt10-1640 99.97% · ILS Laboratories